Home
About
Publications Trends
Recent Publications
Expert Search
Archive
autologous transplants
What Cancers are Treated with Autologous Transplants?
Autologous transplants are commonly used to treat certain types of cancer, including:
Multiple Myeloma
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Certain types of leukemia
In some cases, autologous transplants may also be used for solid tumors such as neuroblastoma and germ cell tumors, although this is less common.
Frequently asked queries:
What are Autologous Transplants?
Why Choose Autologous Transplants?
What Cancers are Treated with Autologous Transplants?
What is the Success Rate?
Who is a Candidate?
How is SAC Failure Detected in Cancer?
What are phytosterols?
How Does Cancer Lead to Hepatic Impairment?
What is the Prognosis for Each Subtype?
Are There Natural Anti-Inflammatory Options?
How Do Binding Sites Influence Cancer Progression?
What Role do Medications Play?
Can Severe Liver Disease be Prevented in Cancer Patients?
Can Targeting Glycolytic Enzymes be a Therapeutic Strategy?
How is Phage Therapy Relevant to Cancer?
How Does Molecular Diagnostics Aid in Early Detection and Monitoring?
How Do Oral Contraceptives Affect Cancer Risk?
How to Identify Sponsored Content?
Which Types of Cancer are Being Investigated?
What are some strategies to reduce cancer treatment costs?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe